An Evaluation of T-Regulatory Cells and Inflammatory Cytokines in Preeclampsia

Bharath Kumar Koppisetty; Prakruti Dash; Gautom K Saharia; Saurav Nayak; Saubhagya K Jena

doi:10.7759/cureus.43379

journal article Aug 12, 2023

An Evaluation of T-Regulatory Cells and Inflammatory Cytokines in Preeclampsia

Bharath Kumar Koppisetty Prakruti Dash Gautom K Saharia Saurav Nayak Saubhagya K Jena

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.43379

Topics

No keywords indexed for this article. Browse by subject →

References

28

[1]

Stefańska K, Zieliński M, Jankowiak M, et al.. Cytokine imprint in preeclampsia. Front Immunol. 2021, 12:667841. 10.3389/fimmu.2021.667841 10.3389/fimmu.2021.667841

[2]

Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995, 155:1151-1164. 10.4049/jimmunol.155.3.1151

[3]

Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004, 5:266-271. 10.1038/ni1037 10.1038/ni1037

[4]

Sasaki Y, Darmochwal-Kolarz D, Suzuki D, et al.. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol. 2007, 149:139-145. 10.1111/j.1365-2249.2007.03397.x 10.1111/j.1365-2249.2007.03397.x

[5]

Koucký M, Malíčková K, Cindrová-Davies T, et al.. Low levels of circulating T-regulatory lymphocytes and short cervical length are associated with preterm labor. J Reprod Immunol. 2014, 106:110-117. 10.1016/j.jri.2014.04.001 10.1016/j.jri.2014.04.001

[6]

Ballesteros A, Mentink-Kane MM, Warren J, Kaplan GG, Dveksler GS. Induction and activation of latent transforming growth factor-β1 are carried out by two distinct domains of pregnancy-specific glycoprotein 1 (PSG1). J Biol Chem. 2015, 290:4422-4431. 10.1074/jbc.M114.597518 10.1074/jbc.m114.597518

[7]

Li X, Shen L, Tan H. Polymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic review. PLoS One. 2014, 9:e97230. 10.1371/journal.pone.0097230 10.1371/journal.pone.0097230

[8]

Hsu P, Nanan RK. Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol. 2014, 5:125. 10.3389/fimmu.2014.00125 10.3389/fimmu.2014.00125

[9]

Areda BG, Gizaw ST, Berdida DH, Kebalo AH. Evaluation of serum lipid profiles, uric acid, and high sensitivity C-reactive protein levels between pregnancy-induced hypertension and normotensive pregnant women attending Ambo University Referral Hospital, Ambo, Ethiopia, 2020: a case-control study. Health Sci Rep. 2022, 5:e806. 10.1002/hsr2.806 10.1002/hsr2.806

[10]

Bettelli E, Carrier Y, Gao W, et al.. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006, 441:235-238. 10.1038/nature04753 10.1038/nature04753

[11]

Kuczma MP, Szurek EA, Cebula A, et al.. Commensal epitopes drive differentiation of colonic T(regs). Sci Adv. 2020, 6:eaaz3186. 10.1126/sciadv.aaz3186 10.1126/sciadv.aaz3186

[12]

Teles A, Schumacher A, Kühnle MC, et al.. Control of uterine microenvironment by foxp3(+) cells facilitates embryo implantation. Front Immunol. 2013, 4:158. 10.3389/fimmu.2013.00158 10.3389/fimmu.2013.00158

[13]

Toldi G, Svec P, Vásárhelyi B, Mészáros G, Rigó J, Tulassay T, Treszl A. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand. 2008, 87:1229-1233. 10.1080/00016340802389470 10.1080/00016340802389470

[14]

Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ, Erwich JJ. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy. 2009, 28:300-311. 10.1080/10641950802601237 10.1080/10641950802601237

[15]

Care AS, Bourque SL, Morton JS, Hjartarson EP, Robertson SA, Davidge ST. Reduction in regulatory T cells in early pregnancy causes uterine artery dysfunction in mice. Hypertension. 2018, 72:177-187. 10.1161/HYPERTENSIONAHA.118.10858 10.1161/hypertensionaha.118.10858

[16]

Zhao JX, Zeng YY, Liu Y. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod Immunol. 2007, 75:71-81. 10.1016/j.jri.2007.06.052 10.1016/j.jri.2007.06.052

[17]

Gomez-Lopez N, Arenas-Hernandez M, Romero R, et al.. Regulatory T cells play a role in a subset of idiopathic preterm labor/birth and adverse neonatal outcomes. Cell Rep. 2020, 32:107874. 10.1016/j.celrep.2020.107874 10.1016/j.celrep.2020.107874

[18]

Peraçoli MT, Menegon FT, Borges VT, de Araújo Costa RA, Thomazini-Santos IA, Peraçoli JC. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia. J Reprod Immunol. 2008, 79:79-84. 10.1016/j.jri.2008.08.001 10.1016/j.jri.2008.08.001

[19]

Yusrawati Y, Aidina D, Yerizel E. Comparison of transforming growth factor-beta 1 concentration in preeclampsia and normal pregnancy women. Indones Biomed J. 2017, 9:49. 10.18585/inabj.v9i1.310 10.18585/inabj.v9i1.310

[20]

Huber A, Hefler L, Tempfer C, Zeisler H, Lebrecht A, Husslein P. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand. 2002, 81:168-171. 10.1034/j.1600-0412.2002.810214.x 10.1034/j.1600-0412.2002.810214.x

[21]

Wang X, Wang T, Wang J, Niu X, Wang K, Hao Z, Gao H. Circulating transforming growth factor-β1 levels in preeclamptic women: a meta-analysis. Reprod Sci. 2023, 30:1952-1964. 10.1007/s43032-022-01156-x 10.1007/s43032-022-01156-x

[22]

Makar AB, McMartin KE, Palese M, Tephly TR. Formate assay in body fluids: application in methanol poisoning. Biochem Med. 1975, 13:117-126. 10.1016/0006-2944(75)90147-7 10.1016/0006-2944(75)90147-7

[23]

Perucci LO, Gomes KB, Freitas LG, et al.. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS One. 2014, 9:e97632. 10.1371/journal.pone.0097632 10.1371/journal.pone.0097632

[24]

Aggarwal R, Jain AK, Mittal P, Kohli M, Jawanjal P, Rath G. Association of pro- and anti-inflammatory cytokines in preeclampsia. J Clin Lab Anal. 2019, 33:e22834. 10.1002/jcla.22834 10.1002/jcla.22834

[25]

Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet. 2001, 75:243-249. 10.1016/S0020-7292(01)00499-4 10.1016/s0020-7292(01)00499-4

[26]

Afshari JT, Ghomian N, Shameli A, et al.. Determination of interleukin-6 and tumor necrosis factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy Childbirth. 2005, 5:14. 10.1186/1471-2393-5-14 10.1186/1471-2393-5-14

[27]

Kara AE, Guney G, Tokmak A, Ozaksit G. The role of inflammatory markers hs-CRP, sialic acid, and IL-6 in the pathogenesis of preeclampsia and intrauterine growth restriction. Eur Cytokine Netw. 2019, 30:29-33. 10.1684/ecn.2019.0423 10.1684/ecn.2019.0423

[28]

Lumbreras-Marquez MI, Lumbreras-Marquez J, Barraza-Salas M, et al.. Maternal and umbilical cord procalcitonin, high-sensitivity C-reactive protein, and interleukin-6 levels in preeclamptic and normotensive patients: a cross-sectional study. Pregnancy Hypertens. 2020, 21:218-223. 10.1016/j.preghy.2020.04.009 10.1016/j.preghy.2020.04.009

Metrics

0

Citations

28

References

Details

Published: Aug 12, 2023

Authors

B

Bharath Kumar Koppisetty

Cite This Article

Bharath Kumar Koppisetty, Prakruti Dash, Gautom K Saharia, et al. (2023). An Evaluation of T-Regulatory Cells and Inflammatory Cytokines in Preeclampsia. Cureus. https://doi.org/10.7759/cureus.43379

An Evaluation of T-Regulatory Cells and Inflammatory Cytokines in Preeclampsia

You May Also Like